NVIDIAvsZepp Health

NVDA and ZEPP stock compared: price, dividend, valuation and results, from SEC filings.

NVDA

NVIDIA Corporation

$125.53

Value $3.05T

-14.01%
NVDA's page

NVIDIA (NVDA) has a market value of $3.05T and Zepp Health (ZEPP) $37M. Over the last year, with dividends, NVDA moved -32.5% and ZEPP -90.4%. Dividend yield: NVDA 0.41%, ZEPP none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NVDA$3.05T

    ZEPP$37M

    NVDA is 83,041 times ZEPP

  • Revenue, 12 months

    NVDA$303B

    ZEPP$259M

    NVDA is 1,170 times ZEPP

  • Net income, 12 months

    NVDA$193B

    ZEPP-$40M

  • Operating margin

    NVDA65.2%

    ZEPP-11.3%

    76.5 points apart

  • ROIC

    NVDA95.6%

    ZEPP-6.0%

    101.6 points apart

  • P/E

    NVDA15.8

    ZEPP–

  • Dividend yield

    NVDA0.4%

    ZEPP0.0%

    0.4 points apart

  • 5-year return

    NVDA+282.2%

    ZEPP-92.3%

    374.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NVDA+282.2%

ZEPP-92.3%

025050075020222023202420252026
Returns by period
PeriodNVDAWith dividendsZEPPWith dividends
1 year since November 19, 2025-32.5%Price -32.7%-90.4%Price -90.4%
3 years since November 20, 2023+149.8%+35.7% a yearPrice +149.0%-57.2%-24.7% a yearPrice -57.2%
5 years since November 19, 2021+282.2%+30.8% a yearPrice +280.5%-92.3%-40.1% a yearPrice -92.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NVDANVIDIAZEPPZepp Health

Valuation

NVDAZEPP
Valuation
Price$125.53$2.31
Market value$3.05T$37M
Enterprise value (EV)$3.03T$151M
P/E15.8–
P/E, 5-year median49.9–
P/B13.30.2
EV/EBIT15.3–
Free cash flow yield4.2%–

Results and growth

NVDAZEPP
Results and growth
Revenue, 12 months$303B$259M
Net income, 12 months$193B-$40M
Free cash flow, 12 months$127B-$26M
Earnings per share, 12 months$7.91-$2.56
Revenue growth, year on year65.5%41.8%
Revenue growth a year, past+66.9%over 5 years-23.5%over 5 years
EPS growth a year, past+95.2%over 5 years–

Margins and returns on capital

NVDAZEPP
Margins and returns on capital
Gross margin74.7%38.3%
Operating margin65.2%-11.3%
Net margin63.7%-15.5%
ROIC95.6%-6.0%
ROE120.4%-18.7%

Balance sheet

NVDAZEPP
Balance sheet
Cash$56.6B$57M
Total debt$38.9B$173M
Net debt / EBITDA-0.1–
Interest cover426.7×-5.1×

Dividends and buybacks

NVDAZEPP
Dividends and buybacks
Dividend yield0.4%–
Dividend per share, 12 months$0.52–
Dividend growth a year, past+20.1%over 5 years–
Buyback yield1.3%3.4%
Shareholder yield1.7%3.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NVDA or ZEPP

Didn't find what you were looking for?

Ask us
Which is bigger, NVIDIA or Zepp Health?

By market value, NVIDIA ($3.05T) is about 83,040.7 times Zepp Health ($37M), at today's prices.

How did NVDA and ZEPP stock do over the last 5 years?

Since November 19, 2021, NVDA's price moved +280.5% and ZEPP's -92.5%. With dividends: NVDA +282.2% (+30.8% a year), ZEPP -92.3% (-40.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, NVDA or ZEPP?

The dividend yield at today's price is 0.41% for NVIDIA and none for Zepp Health. Over the last twelve months they paid $0.52 and – per share.

Which has the higher profit margins, NVIDIA or Zepp Health?

Over the last twelve months, the net margin was 63.7% for NVIDIA and -15.5% for Zepp Health, and the operating margin 65.2% and -11.3%. Revenue was $303B and $259M.

Which is the better investment, NVIDIA or Zepp Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.